SARS-CoV2 has led to a global pandemic affecting almost 3 million people in almost over 3 months. Various clinical presentations have been reported so far and no definite therapy is established. Anticoagulation is recommended by several experts to address the potential prothrombotic complications from COVID-19, but its safety and regimen need further clinical trials and safety and efficacy profile. Here, we present three cases of intracranial hemorrhage in three critically ill patients with COVID-19 and discuss their course in relation to various regimens of anticoagulation used.

中文翻译：

---

3例住院的COVID-19患者颅内出血并发抗凝预防性治疗。

SARS-CoV2导致全球流行，在近三个月的时间里影响了近300万人。迄今为止，已经报道了各种临床表现，还没有确定的治疗方法。几位专家建议抗凝治疗COVID-19可能引起的血栓形成并发症，但其安全性和方案尚需进一步的临床试验以及安全性和有效性。在这里，我们介绍了3例COVID-19的重症患者的3例颅内出血，并讨论了其与各种抗凝方案相关的过程。